Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct to confusion: lessons learned from marketing BRCA testing.

The American journal of bioethics : AJOB - 1 Jun 2008

Matloff Ellen, Caplan Arthur

Abstract excerpt

Myriad Genetics holds a patent on testing for the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2, and therefore has a forced monopoly on this critical genetic test. Myriad launched a Direct-to-Consumer (DTC) marketing campaign in the Northeast United States in September 2007 and plans to expand that campaign to Florida and Texas in 2008. The ethics of Myriad's patent, forced monopoly and DTC campaign...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotechnology
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Health Services Accessibility

Share to Ovarian Neoplasms

Share to Patents as Topic

Share to Public Health

Source

Identifiers

PMID: 18726769
DOI: 10.1080/15265160802248179

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct to confusion: lessons learned from marketing BRCA testing.PMID 18726769Read ↗

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.Semantic proximity Read ↗

ACOG Committee Opinion No. 409: Direct-to-Consumer Marketing of Genetic TestingSemantic proximity Read ↗

Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization.Semantic proximity Read ↗

Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

Using lessons learned from BRCA testing and marketing: what lies ahead for whole genome scanning services.Semantic proximity Read ↗

Reading between the lines: direct-to-consumer advertising of genetic testing.Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Myriad Genetics: In the eye of the policy storm.Semantic proximity Read ↗

Direct-to-consumer genetic testing: perceptions, problems, and policy responses.Semantic proximity Read ↗

The impact of direct-to-consumer marketing of cancer genetic testing on women according to their genetic risk.Semantic proximity Read ↗

Perception of Direct‐To‐Consumer Genetic Testing and Direct‐To‐Consumer Advertising of Genetic Tests among Members of a Large Managed Care OrganizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.